Vascular endothelial growth factor (VEGF) is the major endothelial mitogen in central nervous system neoplasms and it is expressed in 64-95% of glioblastomas (GBMs). Tumour cells are the main source of VEGF in GBMs whereas VEGF receptors (VEGFR-1, its soluble form sVEGFR-1, VEGFR-2 and neuropilin-1)
Angiogenesis in vestibular schwannomas: Expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1
✍ Scribed by Martin Nue Møller; Kim Werther; Amarnadh Nalla; Sven-Eric Stangerup; Jens Thomsen; Thorkild C. Bøg-Hansen; Hans Jørgen Nielsen; Per Cayé-Thomasen
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 618 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Objectives/Hypothesis:
Vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) are potent mediators of tumor angiogenesis. It has been demonstrated that vestibular schwannoma VEGF expression correlates with tumor growth pattern, whereas knowledge on the expression of MMPs is lacking. This study targets the angiogenic process by investigation of tumor expression of MMP‐2, MMP‐9, and tissue inhibitors of metalloproteinase (TIMP)‐1. A possible correlation with gender, patient age, symptom duration, tumor size, and the absolute and relative growth rate is explored.
Study Design:
Prospective vestibular schwannoma tissue sampling for ELISA and immunohistochemical determination of MMP‐2, MMP‐9 and TIMP‐1.
Methods:
Thirty‐four patients with a sporadic, noncystic, vestibular schwannoma were selected prospectively. Repeated, preoperative magnetic resonance imaging determined the tumor growth pattern. Following translabyrinthine resection, an enzyme‐linked immunosorbent assay was used for determination of the MMP‐2, MMP‐9, and TIMP‐1 concentration in tumor sample homogenates. Immunohistochemical labeling was performed in 12 randomly selected tumors.
Results:
All tumor homogenates expressed measurable MMP‐9, MMP‐2, and TIMP‐1. Immunolabeling localized MMP‐9 expression to the tumor cells, whereas MMP‐2 and TIMP‐1 was found interstitially. A significant correlation existed between the concentration MMP‐9 and absolute tumor growth rate, whereas a weak correlation occurred for the relative growth rate.
Conclusions:
Vestibular schwannomas express MMP‐2, MMP‐9, and TIMP‐1 and the tumor concentration of MMP‐9 correlates with absolute tumor growth rate, but not with age, gender, symptom duration, or preoperative tumor size. No correlations existed between any clinical parameter and MMP‐2 or TIMP‐1 expression. We conclude that MMP‐9 appears to be involved in the growth of vestibular schwannomas. Laryngoscope, 2010
📜 SIMILAR VOLUMES
Enhanced expression of the type IV collagenases MMP-2 and MMP-9, or lack of their inhibitors TIMP-1 and TIMP-2, has been associated with tumour invasion and metastatic potential in several experimental models. Regulation of enzyme activity is clearly a key step in tumour invasion, and recently a pot
## Abstract Tumor progression and metastasis contribute to the great majority of breast cancer deaths. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are thought to be involved in tumor progression and metastasis. Thus, we determined whether the expression of M
Hepatocyte growth factor/scatter factor (HGF/SF) contributes to the malignant progression of human gliomas. We investigated the effect of HGF/SF on matrix metalloproteinase-2 (MMP-2), membrane type 1 matrix metalloproteinase (MT1-MMP) and tissue inhibitors of metalloproteinases (TIMPs), expressions